are you suggesting that HSP and Amphastar's products are closer to Lovenox that TEVA's?
No, not at all. Rather, I’m challenging RockRat to explain why he finds it unfathomable that Teva could have behaved in a manner similar to Amphastar and HSP.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”